Ukrainian Firm To Receive mRNA Tech Transfer From WHO Hub

The Ukrainian pharma firm Darnitsa, which is the latest firm to benefit from the WHO’s mRNA coronavirus vaccine initiative, says it is continuing production amidst the continuing Russian attacks on the country. Meanwhile, the European Medicines Agency has issued guidance for sponsors on methodological aspects of trials affected by the war.

Ukraine flag
The war in Ukraine is affecting clinical trials and drug distribution • Source: Alamy

Ukraine is to be the 15th country to receive support from the World Health Organization’s mRNA technology transfer hub in South Africa, which will allow it to use the technology to produce coronavirus vaccines and possibly other products.

The announcement came as Russian forces intensified their bombardment of Donbas in eastern Ukraine in an apparent effort to take...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography